Iron, hepcidin, and increased atherosclerosis in systemic lupus erythematosus

International Journal of Cardiology

Volumn 131, Issue 1, 2008, Pages

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b   Sullivan, Jerome L ^c  

^a Sanitary Service   (Italy)

^b Ospedale di San Vito al Tagliamento   (Italy)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Hepcidin; Iron; Systemic lupus erythematosus

Indexed keywords

HEPCIDIN; INTERLEUKIN 6; IRON;

ANEMIA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE MARKER; FAMILIAL HYPERCHOLESTEROLEMIA; FERRITIN BLOOD LEVEL; HEART INFARCTION; HETEROZYGOSITY; HUMAN; INCIDENCE; IRON ABSORPTION; IRON BLOOD LEVEL; IRON CHELATION; IRON RESTRICTION; IRON STORAGE; NONHUMAN; PHLEBOTOMY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; HUMANS; IRON; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 56749183592     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.050     Document Type: Article

References (15)

1. Westerweel P.E., Luyten R.K., Koomans H.A., Derksen R.H., and Verhaar M.C. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 56 (2007) 1384-1396
2. Hill J.S., Hayden M.R., Frohlich J., and Pritchard P.H. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb 11 (1991) 290-297
3. Manzi S., Meilahn E.N., Rairie J.E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145 (1997) 408-415
4. Roman M.J., Shanker B.A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2399-2406
5. Mascitelli L., and Pezzetta F. High iron stores and cardiovascular disease in systemic lupus erythematosus. J Intern Med 258 (2005) 584
6. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 (1981) 1293-1294
7. Ganz T., and Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 290 (2006) G199-G203
8. Beyan E., Beyan C., Demirezer A., Ertugrul E., and Uzuner A. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol 32 (2003) 225-228
9. Sabry A., Sheashaa H., El Husseini A., et al. Proinflammatory cytokines (TNF-[alpha] and IL-6) in Egyptian patients with SLE: Its correlation with disease activity. Cytokine 35 (2006) 148-153
10. Ripley B.J.M., Goncalves B., Isenberg D.A., Latchman D.S., and Rahman A. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis 64 (2005) 849-853
11. Li W., Ostblom M., Xu L.H., et al. Cytocidal effects of atheromatous plaque components: the death zone revisited. FASEB J 20 (2006) 2281-2290
12. Minqin R., Rajendran R., Pan N., et al. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic Biol Med 38 (2005) 1206-1211
13. Lee T.S., Shiao M.S., Pan C.C., and Chau L.Y. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99 (1999) 1222-1229
14. Lee H.T., Chiu L.L., Lee T.S., Tsai H.L., and Chau L.Y. Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice. J Biomed Sci 10 (2003) 510-517
15. Sullivan J.L. Macrophage iron, hepcidin and atherosclerotic plaque stability. Exp Biol Med 232 (2007) 1014-1020